The diagnostic armamentarium for solid tumors is evolving rapidly, redefining how we detect, stage, stratify, monitor, and ultimately treat cancer. This ...

Yale School of Medicine (YSM) scientists have discovered a molecular difference in the brains of autistic people compared to ...

A new imaging technology can distinguish cancerous tissue from healthy cells by detecting ultra-weak light signals. It relies ...

When you take a drug, where in your body does it actually go? For most medications, scientists can make only educated guesses ...

The ability of Raman spectroscopy to identify molecular-level spectral fingerprints has made it an attractive route to diagnostic information and identification of early-stage tumors, especially in ...

Plants form a critical model for understanding regulated cell death (RCD) as part of their sophisticated immune responses. In the ongoing evolutionary arms ...

Symptoms of stage 3 RCC vary; some patients experience blood in the urine, flank pain, fatigue, weight loss, or a palpable ...

Cancer imaging is entering a phase where malignant cells no longer hide in murky grayscale but flare into view with surgical ...

A research team led by Félix Viana, co-director of the Sensory Transduction and Nociception laboratory at the Institute for Neurosciences (IN), a joint research centre of the Spanish National Research ...

New research tracks how THC exposure during pregnancy disrupts fetal brain development and leads to sustained structural ...

Through a novel combination of machine learning and atomic force microscopy, researchers in China have unveiled the molecular ...

Findings from a study on the utility of ultrasensitive circulating tumor DNA (ctDNA) as a predictive biomarker for patients ...